why choose us

First received: November 15, 2022

Clinical Trial: Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Developmental and Epileptic Encephalopathy

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy Who Completed Study LP352-201 and Are Candidates for Continuous Treatmen

Brief Summary: The objective of this study is to assess the long-term safety, tolerability, and efficacy of adjunctive therapy of LP352 in subjects with developmental and epileptic encephalopathies who completed participation in Study LP352-201.

Read more